The proline-rich domain of dynamin-2 is responsible for dynamin-dependent in vitro potentiation of endothelial nitric-oxide synthase activity via selective effects on reductase domain function

The proline-rich domain of dynamin-2 is responsible for dynamin-dependent in vitro potentiation of endothelial nitric-oxide synthase activity via selective effects on reductase domain function
复制标题

DOI:
10.1074/jbc.m212546200
复制
发表时间:
2003-02-21
影响因子:
4.8
通讯作者:
Shah, V
Shah, V
中科院分区:
生物学2区
文献类型:
--
作者:
Cao, S;Yao, J;Shah, V

文献摘要

被引文献

相似文献

GTPase dynamin-2 (dyn-2)结合并正向调节一氧化氮生成酶内皮一氧化氮合成酶(eNOS) (Cao, S., Yao, Y., McCabe, T., Yao, Q., Katusic, Z., Sessa, W., and Shah, V. (2001) J. Biol。276年化学,14249 - 14256)。在这里,我们使用纯化蛋白证明,这是通过dyn-2脯氨酸丰富结构域(dyn-2 PRD)对eNOS还原酶结构域的选择性影响发生的。体外研究表明,与谷胱甘肽s转移酶(GST)融合的dyn-2 PRD可以特异性结合重组eNOS蛋白,其结合动力学与dyn-2全长与eNOS的结合动力学相当。此外,GST-dyn-2 PRD结合体外转录的S-35-eNOS还原酶结构域,但不结合35 S-eNOS加氧酶结构域。此外,GST-dyn-2 PRD结合s -35标记的eNOS还原酶结构域片段(氨基酸645-850),该片段与eNOS的FAD结合结构域部分重叠。含sh3蛋白Fyn的重组形式竞争重组eNOS蛋白与dyn-2 PRD的结合,从而暗示该还原酶结构域片段中包含的sh3样区域是dyn-2结合区域。哺乳动物双杂交实验也证实了细胞间的相互作用。功能研究表明,dyn-2 PRD以浓度依赖的方式选择性地增强eNOS活性,其数量级与dyn-2全长所观察到的相似,并且需要钙调素。虽然dyn-2 PRD不影响eNOS加氧酶结构域功能或铁氰化物还原,但它确实增强了重组eNOS降低细胞色素c的能力,支持dyn-2 PRD对FAD和FMN之间电子转移的影响。(这些数据表明dyn-2和eNOS的结合域分别位于dyn-2 PRD结构域和eNOS还原酶结构域的FAD结合区,dyn-2 PRD足以介导eNOS活性的dyn-2依赖性增强,至少部分是通过增强电子转移。)
The GTPase dynamin-2 (dyn-2) binds and positively regulates the nitric oxide-generating enzyme, endothelial nitric-oxide synthase (eNOS) (Cao, S., Yao, Y., McCabe, T., Yao, Q., Katusic, Z., Sessa, W., and Shah, V. (2001) J. Biol. Chem. 276,14249-14256). Here we demonstrate, using purified proteins, that this occurs through a selective influence of the dyn-2 proline-rich domain (dyn-2 PRD) on the eNOS reductase domain. In vitro studies demonstrate that dyn-2 PRD fused with glutathione S-transferase (GST) binds recombinant eNOS protein specifically and with binding kinetics comparable with that observed between dyn-2 full-length and eNOS. Additionally, GST-dyn-2 PRD binds the in vitro transcribed S-35-eNOS reductase domain but not the 35 S-eNOS oxygenase domain. Furthermore GST-dyn-2 PRD binds a S-35-labeled eNOS reductase domain fragment (amino acids 645-850) that partially overlaps with the FAD binding domain of eNOS. A recombinant form of the SH3-containing protein Fyn competes the binding of recombinant eNOS protein with dyn-2 PRD, thereby implicating the SH3-like region contained within this reductase domain fragment as the dyn-2 binding region. Mammalian two-hybrid screen corroborates these interactions in cells as well. Functional studies demonstrate that dyn-2 PRD selectively potentiates eNOS activity in a concentration-dependent manner in an order of magnitude similar to that observed with dyn-2 full-length and in a manner that requires calmodulin. Although dyn-2 PRD does not influence eNOS oxygenase domain function or ferricyanide reduction, it does potentiate the ability of recombinant eNOS to reduce cytochrome c, supporting an influence of dyn-2 PRD on electron transfer between FAD and FMN. (These data indicate that the binding domains of dyn-2 and eNOS reside within the dyn-2 PRD domain and the FAD binding region of the eNOS reductase domains, respectively, and that dyn-2 PRD is sufficient to mediate dyn-2-dependent potentiation of eNOS activity, at least in part, by potentiating electron transfer.).